| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | 600 | 0 | 0 | 577 | 1.265 | 4.442 |
| Total Income - EUR | - | - | - | - | 600 | 0 | 0 | 577 | 1.265 | 4.442 |
| Total Expenses - EUR | - | - | - | - | 5 | 0 | 0 | 4 | 463 | 2.750 |
| Gross Profit/Loss - EUR | - | - | - | - | 595 | 0 | 0 | 572 | 801 | 1.692 |
| Net Profit/Loss - EUR | - | - | - | - | 577 | 0 | 0 | 555 | 673 | 1.421 |
| Employees | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Doracor Hematomed S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | - | - | - | - | 648 | 636 | 0 | 624 | 1.401 | 2.688 |
| Inventories | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | - | - | - | 23 | 22 | 0 | 22 | 0 | 2.097 |
| Cash | - | - | - | - | 625 | 614 | 0 | 602 | 1.401 | 591 |
| Shareholders Funds | - | - | - | - | 619 | 607 | 0 | 596 | 1.267 | 2.681 |
| Social Capital | - | - | - | - | 42 | 41 | 0 | 41 | 40 | 40 |
| Debts | - | - | - | - | 29 | 29 | 0 | 28 | 134 | 7 |
| Income in Advance | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Doracor Hematomed S.r.l.